BIVI BIOVIE INC revenue, earnings and financials
For the quarter ended March 31, 2026, BIOVIE INC reported revenue of n/a, net income of −$5.27M and diluted EPS of −$0.70; for the fiscal year ended June 2025 revenue was n/a.
BIVI annual revenue and earnings
- Fiscal year ended Jun 2025: revenue n/a, gross profit n/a, operating income −$18.1M, net income −$17.5M (margin n/a), EPS −$12.12
- Fiscal year ended Jun 2024: revenue n/a, gross profit n/a, operating income −$32.2M, net income −$32.1M (margin n/a), EPS −$73.05
- Fiscal year ended Jun 2023: revenue n/a, gross profit n/a, operating income −$45.1M, net income −$50.3M (margin n/a), EPS −$15.47
- Fiscal year ended Jun 2022: revenue n/a, gross profit n/a, operating income −$27.3M, net income −$26.1M (margin n/a), EPS −$1.06
- Fiscal year ended Jun 2021: revenue n/a, gross profit n/a, operating income −$138M, net income −$130M (margin n/a), EPS −$14.82
BIVI quarterly revenue and earnings
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.27M, EPS −$0.70
- Quarter ended Dec 31, 2025: revenue n/a, net income −$6.07M, EPS −$0.77
- Quarter ended Sep 30, 2025: revenue n/a, net income −$5.09M, EPS −$0.98
- Quarter ended Jun 30, 2025 (from the annual report): revenue n/a, net income −$3.49M, EPS $0.94
- Quarter ended Mar 31, 2025: revenue n/a, net income −$2.79M, EPS −$1.51
- Quarter ended Dec 31, 2024: revenue n/a, net income −$7.11M, EPS −$4.55
- Quarter ended Sep 30, 2024: revenue n/a, net income −$4.15M, EPS −$7.00
- Quarter ended Jun 30, 2024 (from the annual report): revenue n/a, net income −$4.94M, EPS −$65.93
- Quarter ended Mar 31, 2024: revenue n/a, net income −$8.07M, EPS −$2.00
- Quarter ended Dec 31, 2023: revenue n/a, net income −$8.40M, EPS −$2.20
- Quarter ended Sep 30, 2023: revenue n/a, net income −$10.7M, EPS −$2.92
- Quarter ended Jun 30, 2023 (from the annual report): revenue n/a, net income −$9.11M, EPS −$14.16
- Quarter ended Mar 31, 2023: revenue n/a, net income −$15.0M, EPS −$0.43
- Quarter ended Dec 31, 2022: revenue n/a, net income −$15.7M, EPS −$0.50
- Quarter ended Sep 30, 2022: revenue n/a, net income −$10.4M, EPS −$0.38
- Quarter ended Jun 30, 2022 (from the annual report): revenue n/a, net income −$8.09M, EPS −$0.33
- Quarter ended Mar 31, 2022: revenue n/a, net income −$7.04M, EPS −$0.28
- Quarter ended Dec 31, 2021: revenue n/a, net income −$5.41M, EPS −$0.22
- Quarter ended Sep 30, 2021: revenue n/a, net income −$5.54M, EPS −$0.23
- Quarter ended Mar 31, 2021: revenue n/a, net income −$2.99M, EPS −$0.22
BIVI cash flow, buybacks and dividends
- Fiscal year ended Jun 2025: operating cash flow −$19.0M, share buybacks n/a
- Fiscal year ended Jun 2024: operating cash flow −$27.9M, share buybacks n/a
- Fiscal year ended Jun 2023: operating cash flow −$40.3M, share buybacks n/a
- Fiscal year ended Jun 2022: operating cash flow −$19.0M, share buybacks n/a
- Fiscal year ended Jun 2021: operating cash flow −$10.5M, share buybacks n/a
BIVI balance sheet
- Jun 30, 2026: cash $8.98M, total assets $14.3M, total liabilities $3.98M, shareholders' equity $10.3M
- Mar 31, 2026: cash $13.1M, total assets $17.5M, total liabilities $1.91M, shareholders' equity $15.6M
- Dec 31, 2025: cash $20.5M, total assets $22.5M, total liabilities $3.24M, shareholders' equity $19.3M
- Sep 30, 2025: cash $25.0M, total assets $26.8M, total liabilities $1.90M, shareholders' equity $24.9M
- Jun 30, 2025: cash $17.5M, total assets $21.6M, total liabilities $2.55M, shareholders' equity $19.0M
- Mar 31, 2025: cash $23.2M, total assets $24.7M, total liabilities $2.84M, shareholders' equity $21.8M
- Dec 31, 2024: cash $24.4M, total assets $25.7M, total liabilities $1.77M, shareholders' equity $23.9M
- Sep 30, 2024: cash $20.0M, total assets $21.2M, total liabilities $7.17M, shareholders' equity $14.1M
Is BIVI profitable?
No. BIOVIE INC lost $19.9M over the last four quarters.
What is BIVI's EPS?
Diluted earnings per share over the last four quarters were −$1.51; −$0.70 in the latest quarter.